RecruitingNot ApplicableNCT06597851

Insulin Resistance and Coronary Microvascular Dysfunction in Patients with Myocardial Ischemia and Non-obstructive Coronary Artery Disease


Sponsor

Azienda Ospedaliera Universitaria Integrata Verona

Enrollment

40 participants

Start Date

Jun 24, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this prospective study is to assess the correlation between coronary microvascular disfunction and insulin resistance in patients with INOCA. Patients with ANOCA and without diabetes will undergo invasive coronary microvascular assessment through coronary angiography and insulin resistance assessment through hyperinsulinemic-euglycemic clamp test. Patients enrolled in the study will be followed for a period of 2 years to monitor their clinical status.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Aged over 18 years.
  • Cardiac chest pain with evidence of myocardial ischemia at noninvasive myocardial stress imaging and clinical indication to diagnostic coronary angiography
  • Willing and able to give informed consent for participation in the study

Exclusion Criteria8

  • Obstructive CAD (defined as more than 70% luminal stenosis and/or FFR ≤0.80 in 1 or more epicardial vessels).
  • History of previous myocardial infarction, percutaneous revascularization or coronary-aortic bypass graft (CABG) surgery.
  • Diagnosis of type II diabetes.
  • BMI ≥ 35 kg/m2.
  • Stage IV and V of chronic kidney disease (eGFR ≤ 30 ml/min, estimated through CKD - EPI Creatinine Equation).
  • Allergy or other contraindication to iodinated contrast and/or gadolinium and/or adenosine.
  • Chronic resting O2 saturation ≤ 85%.
  • Pregnancy or suspected pregnancy.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTThermodilution based assessment of coronary microcirculation

Coronary microvascular assessment with the derivation of CFR, IMR and MRR will be performed using a standard pressure/thermodilution guidewire.

DIAGNOSTIC_TESTHyperinsulinemic-euglycemic Clamp test

Infusion of insulin and glucose adjusting rate of glucose infusion to maintaine plasma glucose around 90 mg/dL by monitoring plasma glucose levels every 5-10 minutes


Locations(1)

Azienda Ospedaliera Universitaria di Verona

Verona, VR, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06597851


Related Trials